MAP3K19	NN	MAP3K19 GENE TermTag
Is	VBZ	be O TermTag
a	DT	a dt NUPOS
Novel	JJ	novel O TermTag
Regulator	NNP	regulator O TermTag
of	IN	of O TermTag
TGF-b	NNP	TGF-b GENE TermTag
Signaling	NN	signaling O TermTag
That	WDT	That O TermTag
Impacts	VBZ	impact O TermTag
Bleomycin-Induced	JJ	bleomycin-induced O TermTag
Lung	NN	lung O TermTag
Injury	NNP	injury O TermTag
and	CC	and O TermTag
Pulmonary	NNP	Pulmonary O TermTag
Fibrosis	NNP	fibrosis O TermTag
.	.	. . NUPOS

UNASSIGNED	NNP	UNASSIGNED O TermTag
:	:	: : NUPOS
Idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
(	(	( ( NUPOS
IPF	NN	IPF O TermTag
)	)	) ) NUPOS
is	VBZ	be O TermTag
a	DT	a dt NUPOS
progressive	JJ	progressive O TermTag
,	,	, , NUPOS
debilitating	JJ	debilitating O TermTag
disease	NN	disease O TermTag
for	IN	for O TermTag
which	WDT	which O TermTag
two	CD	two O TermTag
medications	NNS	medication O TermTag
,	,	, , NUPOS
pirfenidone	NN	pirfenidone O TermTag
and	CC	and O TermTag
nintedanib	NN	nintedanib O TermTag
,	,	, , NUPOS
have	VBP	have O TermTag
only	RB	only O TermTag
recently	RB	recent O TermTag
been	VBN	be O TermTag
approved	VBN	approve O TermTag
for	IN	for O TermTag
treatment	NN	treatment O TermTag
.	.	. . NUPOS

The	DT	the O TermTag
cytokine	NN	cytokine O TermTag
TGF-b	NN	TGF-b GENE TermTag
has	VBZ	have O TermTag
been	VBN	be O TermTag
shown	VBN	show O TermTag
to	TO	to O TermTag
be	VB	be O TermTag
a	DT	a dt NUPOS
central	JJ	central O TermTag
mediator	NN	mediator O TermTag
in	IN	in O TermTag
the	DT	the O TermTag
disease	NN	disease O TermTag
process	NN	process O TermTag
.	.	. . NUPOS

We	PRP	we O TermTag
investigated	VBD	investigate O TermTag
the	DT	the O TermTag
role	NN	role O TermTag
of	IN	of O TermTag
a	DT	a dt NUPOS
novel	JJ	novel O TermTag
kinase	NN	kinase O TermTag
,	,	, , NUPOS
MAP3K19	NN	MAP3K19 GENE TermTag
,	,	, , NUPOS
upregulated	VBN	upregulate O TermTag
in	IN	in O TermTag
IPF	NN	IPF O TermTag
tissue	NN	tissue O TermTag
,	,	, , NUPOS
in	IN	in O TermTag
TGF-b-induced	JJ	tgf-b-induced O TermTag
signal	NN	signal O TermTag
transduction	NN	transduction O TermTag
and	CC	and O TermTag
in	IN	in O TermTag
bleomycin-induced	JJ	bleomycin-induced O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
.	.	. . NUPOS

MAP3K19	NN	MAP3K19 GENE TermTag
has	VBZ	have O TermTag
a	DT	a dt NUPOS
very	RB	very O TermTag
limited	JJ	limited O TermTag
tissue	NN	tissue O TermTag
expression	NN	expression O TermTag
,	,	, , NUPOS
restricted	JJ	restricted O TermTag
primarily	RB	primary O TermTag
to	TO	to O TermTag
the	DT	the O TermTag
lungs	NNS	lung O TermTag
and	CC	and O TermTag
trachea	NN	trachea O TermTag
.	.	. . NUPOS

In	IN	in O TermTag
pulmonary	JJ	pulmonary O TermTag
tissue	NN	tissue O TermTag
,	,	, , NUPOS
expression	NN	expression O TermTag
was	VBD	be O TermTag
predominantly	RB	predominant O TermTag
localized	JJ	localized O TermTag
to	TO	to O TermTag
alveolar	JJ	alveolar O TermTag
and	CC	and O TermTag
interstitial	JJ	interstitial O TermTag
macrophages	NNS	macrophage O TermTag
,	,	, , NUPOS
bronchial	JJ	bronchial O TermTag
epithelial	JJ	epithelial O TermTag
cells	NNS	cell O TermTag
and	CC	and O TermTag
type	NN	type O TermTag
II	CD	II O TermTag
pneumocytes	NNS	pneumocyte O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
epithelium	NN	epithelium O TermTag
.	.	. . NUPOS

MAP3K19	NN	MAP3K19 GENE TermTag
was	VBD	be O TermTag
also	RB	also O TermTag
found	VBN	find O TermTag
to	TO	to O TermTag
be	VB	be O TermTag
overexpressed	VBN	overexpress O TermTag
in	IN	in O TermTag
bronchoalveolar	JJ	bronchoalveolar O TermTag
lavage	NN	lavage O TermTag
macrophages	NNS	macrophage O TermTag
from	IN	from O TermTag
IPF	NN	IPF O TermTag
patients	NNS	patient O TermTag
compared	VBN	compare O TermTag
to	TO	to O TermTag
normal	JJ	normal O TermTag
patients	NNS	patient O TermTag
.	.	. . NUPOS

Treatment	NN	treatment O TermTag
of	IN	of O TermTag
A549	NN	A549 O TermTag
or	CC	or O TermTag
THP-1	NN	THP-1 O TermTag
cells	NNS	cell O TermTag
with	IN	with O TermTag
either	CC	either O TermTag
MAP3K19	NN	MAP3K19 GENE TermTag
siRNA	NN	siRNA O TermTag
or	CC	or O TermTag
a	DT	a dt NUPOS
highly	RB	high O TermTag
potent	JJ	potent O TermTag
and	CC	and O TermTag
specific	JJ	specific O TermTag
inhibitor	NN	inhibitor O TermTag
reduced	VBD	reduce O TermTag
phospho-Smad2	NN	phospho-Smad2 O TermTag
3	CD	3 crd NUPOS
nuclear	JJ	nuclear O TermTag
translocation	NN	translocation O TermTag
following	VBG	follow O TermTag
TGF-b	NN	TGF-b GENE TermTag
stimulation	NN	stimulation O TermTag
.	.	. . NUPOS

TGF-b-induced	JJ	tgf-b-induced O TermTag
gene	NN	gene O TermTag
transcription	NN	transcription O TermTag
was	VBD	be O TermTag
also	RB	also O TermTag
strongly	RB	strong O TermTag
inhibited	VBN	inhibit O TermTag
by	IN	by O TermTag
both	CC	both O TermTag
the	DT	the O TermTag
MAP3K19	NN	MAP3K19 GENE TermTag
inhibitor	NN	inhibitor O TermTag
and	CC	and O TermTag
nintedanib	NN	nintedanib O TermTag
,	,	, , NUPOS
whereas	IN	whereas O TermTag
pirfenidone	NN	pirfenidone O TermTag
had	VBD	have O TermTag
a	DT	a dt NUPOS
much	RB	much O TermTag
less	RBR	little O TermTag
pronounced	JJ	pronounced O TermTag
effect	NN	effect O TermTag
.	.	. . NUPOS

In	IN	in O TermTag
combination	NN	combination O TermTag
,	,	, , NUPOS
the	DT	the O TermTag
MAP3K19	NN	MAP3K19 GENE TermTag
inhibitor	NN	inhibitor O TermTag
appeared	VBD	appear O TermTag
to	TO	to O TermTag
act	VB	act O TermTag
synergistically	RB	synergistic O TermTag
with	IN	with O TermTag
either	CC	either O TermTag
pirfenidone	NN	pirfenidone O TermTag
or	CC	or O TermTag
nintedanib	NN	nintedanib O TermTag
,	,	, , NUPOS
at	IN	at O TermTag
the	DT	the O TermTag
level	NN	level O TermTag
of	IN	of O TermTag
target	NN	target O TermTag
gene	NN	gene O TermTag
transcription	NN	transcription O TermTag
or	CC	or O TermTag
protein	NN	protein O TermTag
production	NN	production O TermTag
.	.	. . NUPOS

Finally	RB	final O TermTag
,	,	, , NUPOS
in	IN	in O TermTag
an	DT	a O TermTag
animal	NN	animal O TermTag
model	NN	model O TermTag
of	IN	of O TermTag
IPF	NN	IPF O TermTag
,	,	, , NUPOS
inhibition	NN	inhibition O TermTag
of	IN	of O TermTag
MAP3K19	NN	MAP3K19 GENE TermTag
strongly	RB	strong O TermTag
attenuated	VBD	attenuate O TermTag
bleomycin-induced	JJ	bleomycin-induced O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
when	WRB	when O TermTag
administered	VBN	administer O TermTag
either	CC	either O TermTag
prophylactically	RB	prophylactical O TermTag
ortherapeutically	RB	ortherapeutical O TermTag
.	.	. . NUPOS

In	IN	in O TermTag
summary	NN	summary O TermTag
,	,	, , NUPOS
these	DT	these O TermTag
results	NNS	result O TermTag
strongly	RB	strong O TermTag
suggest	VBP	suggest O TermTag
that	IN	that O TermTag
inhibition	NN	inhibition O TermTag
of	IN	of O TermTag
MAP3K19	NN	MAP3K19 GENE TermTag
may	MD	may O TermTag
have	VB	have O TermTag
a	DT	a dt NUPOS
beneficial	JJ	beneficial O TermTag
therapeutic	JJ	therapeutic O TermTag
effect	NN	effect O TermTag
in	IN	in O TermTag
the	DT	the O TermTag
treatment	NN	treatment O TermTag
of	IN	of O TermTag
IPF	NN	IPF O TermTag
and	CC	and O TermTag
represents	VBZ	represent O TermTag
a	DT	a dt NUPOS
novel	JJ	novel O TermTag
strategy	NN	strategy O TermTag
to	TO	to O TermTag
target	VB	target O TermTag
this	DT	this O TermTag
disease	NN	disease O TermTag
.	.	. . NUPOS

